Modelling, Access & Strategy
QUANTIFY has extensive experience in developing economic models, gaining market access, and providing strategic advice to our partners in the pharmaceutical industry.
As a global partner, QUANTIFY excels at building global economic models including cost-effectiveness and budget impact models. Each model is designed to reflect the value of the product, incorporating strategic positioning and value messaging within the design and content of the model. QUANTIFY understands the need for fit-for-purpose model design, speed, agility and quality. Our strong technical capabilities and mastery of theoretical health economic principles ensures that we are ready to meet the demands of sophisticated payers such as NICE, without compromising on value demonstration.
As a compliment to the technical rigour of cost-effectiveness and budget impact models, QUANTIFY develops value tools as a complimentary type of economic model. These tools give manufacturers a way to express the value of a product in a way that is intuitive for stakeholders such as payers, physicians, and patients. The value drivers are unique for each product, but may include cost savings resulting from a treatment replacement, reductions in sick leave, events avoided and other types of practical outcomes.